top of page

The EverythingALS Research Network comprises pharmaceutical and biotech companies, neurologists, data scientists, technology companies, sensors, regulators, and patients. Together, we drive forward the discovery and implementation of ALS clinical assessments and digital biomarkers in clinical trials through collaborative efforts.

Join our Research Network and help drive profound advancements in ALS research.

Website Current Edits.png
Lilly.png
1 Rapa.png
Regeneron logo.png
bottom of page